
Silencing the expression of Cbl-b enhances the immune activation of T lymphocytes against RM-1 prostate cancer cells in vitro
Keywords: adoptive immunotherapy; Cbl E3 gene silencing; prostate cancer; T lymphocytes; ubiquitin protein ligase